Home Ingredients Hesperidin
Cardiovascular

Hesperidin

Evidence Level
Moderate
2 Clinical Trials
5 Documented Benefits
3/5 Evidence Score

Hesperidin is a flavanone glycoside found primarily in citrus fruits — particularly oranges, grapefruits, and lemons (highest concentration in peel and pith). Studied for vascular health, chronic venous insufficiency, hemorrhoids, and capillary fragility. Used widely in Europe (combined with diosmin as Daflon®/Detralex®) for venous diseases. The venous evidence is largely for the diosmin+hesperidin combination phlebotonic (Daflon®); evidence for isolated hesperidin as a supplement is more modest and mostly at the level of surrogate biomarkers.

Studied Dose 500-1,000 mg/day general; 450-900 mg/day combined with diosmin for venous insufficiency (Daflon® 500 mg = 450 mg diosmin + 50 mg hesperidin)
Active Compound Hesperidin (4'-methoxy-7-O-rutinosyl-naringenin)

Benefits

Venous & Leg-Vein Support (Diosmin+Hesperidin Combination)

The venous evidence here belongs to the diosmin+hesperidin COMBINATION product (Daflon®/Detralex®, roughly 90% diosmin plus 10% hesperidin), a prescription phlebotonic used in Europe — not to isolated hesperidin. As a standalone dietary supplement, isolated hesperidin has only modest surrogate-biomarker data and is not a treatment for venous disease. This is a structure/function description and is not intended to diagnose, treat, cure, or prevent any disease.

Supported by Trial 1, Trial 2

Hemorrhoid Comfort (Diosmin+Hesperidin Combination)

It is the diosmin+hesperidin COMBINATION drug (predominantly diosmin) — not isolated hesperidin — that European clinical guidelines discuss for hemorrhoidal disease. Isolated hesperidin sold as a dietary supplement has not been established for this use. This is a structure/function description and is not intended to diagnose, treat, cure, or prevent any disease.

Supported by Trial 2, Trial 1

Microcirculation / Capillary Fragility

Traditionally described as a 'venotonic' flavonoid studied for capillary integrity and microcirculation. Human data for isolated hesperidin are limited and mostly surrogate-marker level; it is not an established treatment for diabetes, retinopathy, bruising, or lymphedema.

Supported by Trial 1, Trial 2

Anti-Inflammatory / Antioxidant

Reduces inflammatory markers, oxidative stress, endothelial dysfunction — broad cardiovascular protective effects beyond just venous applications.

Supported by Trial 1

Modest Cardiovascular Risk Marker Effects

Some trials show modest improvements in blood pressure, lipids, endothelial function. Effect smaller than dedicated cardiovascular medications. General CV support component.

Mechanism of action

1

Venotonic / Vasoconstrictor Activity

Hesperidin (and diosmin) increase venous tone and reduce venous distensibility — proposed basis for venous-tone support. Improves valve function and reduces venous reflux.

2

Lymphatic Drainage Enhancement

Increases lymphatic contractility — improves lymph drainage. Relevant for edema, lymphedema, lymphatic stagnation.

3

Anti-Inflammatory / Adhesion Molecule Reduction

Reduces leukocyte adhesion to endothelium, decreases inflammatory cytokines. Limits the inflammatory cascade that contributes to chronic venous disease.

4

Capillary Permeability Reduction

Decreases capillary permeability — reduces fluid leakage, improves capillary integrity. Foundational mechanism for 'capillary fragility' applications.

Clinical trials

1
Hesperidin/Diosmin for CVI — RELIEF Study

Large prospective international study of micronized purified flavonoid fraction (90% diosmin + 10% hesperidin) in 5,052 patients with chronic venous insufficiency for 6 months.

5,052 CVI patients (international).

Significant improvement in CVI symptoms (edema, pain, leg heaviness, cramps), quality of life. Foundational evidence for the diosmin+hesperidin COMBINATION drug (MPFF, ~90% diosmin) in venous insufficiency — not isolated hesperidin. This describes a prescription phlebotonic, not the standalone supplement.

2
Hesperidin/Diosmin for Hemorrhoids — Evidence Synthesis

Pooled analyses and evidence reviews of MPFF (diosmin/hesperidin) for hemorrhoidal disease.

Pooled across hemorrhoid clinical trials.

The diosmin+hesperidin COMBINATION drug (MPFF, predominantly diosmin) — not isolated hesperidin — is what European guidelines discuss for hemorrhoidal symptoms; this is a prescription phlebotonic, not the standalone supplement.

Side effects and drug interactions

Common Potential side effects

Generally very well-tolerated.
Mild GI distress (nausea, abdominal pain, diarrhea).
Headache.
Skin reactions / contact dermatitis rare.
Allergic reactions to citrus rare.
Hot flushes (rare).

Important Drug interactions

Generally minimal drug interactions.
Anticoagulants — minimal effect; theoretical at very high doses.
Calcium channel blockers — theoretical interaction (citrus flavonoids modify CYP3A4); clinically minor.
Pregnancy/lactation — limited safety data for supplementation; avoid; dietary citrus safe.

Featured in these supplement guides

Circulation & Varicose Veins→

More Cardiovascular Ingredients

Cardiovascular
Niacin
Niacin (vitamin B3) is an essential water-soluble vitamin central to energy metabolism, DN…
Cardiovascular
Potassium
Potassium is the most abundant intracellular cation in the human body and an essential min…
Cardiovascular
Phytosterols (Plant Sterols & Stanols)
Phytosterols (plant sterols and stanols) are plant-derived compounds structurally similar…
Cardiovascular
MegaNatural®-BP (Patented Grape Seed Extract — Polyphenolics)
MegaNatural-BP is a patented grape seed extract developed by Polyphenolics (division of Ca…

Explore Other Ingredients

Cognitive
L-Theanine
L-Theanine, an amino acid primarily found in green tea (Camellia sinensis), is commonly su…
Cognitive
Holy Basil (Tulsi)
Holy basil (tulsi) is a revered adaptogenic herb in Ayurvedic tradition, used to help the…
Energy
SalidroPure™ (Pure Salidroside)
SalidroPure™ is NNB Nutrition's precision-fermented pure salidroside — the primary bioacti…

Frequently asked questions about Hesperidin

What is hesperidin used for?

Hesperidin is a flavonoid found in citrus peels (especially oranges). It is studied for supporting blood-vessel and vein health, healthy circulation and blood pressure, and antioxidant activity. It is often combined with diosmin for vein support.

Does hesperidin help with veins or circulation?

Hesperidin, especially with diosmin, is used to support vein tone and healthy circulation, including for tired, heavy legs and hemorrhoid comfort. Its effects on the blood vessels underlie these uses.

How much hesperidin should I take?

Vein-support products often provide hesperidin combined with diosmin (for example 50 mg hesperidin with 450 mg diosmin). For other uses, follow product labeling, commonly a few hundred milligrams per day.

Is hesperidin safe?

Hesperidin is generally well tolerated, with citrus being a natural source. It may mildly affect blood pressure and interact with some medications, so check with your doctor if you take blood-pressure or blood-thinning drugs.

What is Hesperidin?

Hesperidin is a flavanone glycoside found primarily in citrus fruits — particularly oranges, grapefruits, and lemons (highest concentration in peel and pith). Studied for vascular health, chronic venous insufficiency, hemorrhoids, and capillary fragility.

What is the recommended dosage of Hesperidin?

The clinically studied dose is 500-1,000 mg/day general; 450-900 mg/day combined with diosmin for venous insufficiency (Daflon® 500 mg = 450 mg diosmin + 50 mg hesperidin) Always follow the product label and check with a healthcare provider for personal advice.

Is Hesperidin safe, and does it have side effects?

For most healthy adults, Hesperidin is well tolerated at studied doses. Reported effects can include: Generally very well-tolerated. Mild GI distress (nausea, abdominal pain, diarrhea). It may also interact with some medications. Hesperidin is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Hesperidin interact with any medications?

Possible interactions include: Generally minimal drug interactions. Anticoagulants — minimal effect; theoretical at very high doses. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Hesperidin?

NutraSmarts rates the evidence for Hesperidin as Moderate (3 out of 5). It is backed by 2 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Morand C, Dubray C, Milenkovic D, Lioger D, Martin JF, Scalbert A, et al. Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers. The American Journal of Clinical Nutrition. 2011;93(1):73-80. doi: 10.3945/ajcn.110.004945.PubMedUsed to support: Backs the venous/endothelial-tone and microcirculation signal: isolated hesperidin (vs control drink) improved diastolic blood pressure and microvascular endothelial reactivity in a crossover RCT. Real but limited evidence — single acute crossover in healthy volunteers using orange-juice-matched dosing.
  2. Milenkovic D, Deval C, Dubray C, Mazur A, Morand C Hesperidin displays relevant role in the nutrigenomic effect of orange juice on blood leukocytes in human volunteers: a randomized controlled cross-over study. PLoS One. 2011;6(11):e26669. doi: 10.1371/journal.pone.0026669.PubMedUsed to support: Mechanistic support for the vascular/endothelial claim: isolated hesperidin drove much of the gene-expression (nutrigenomic) shift in leukocytes toward an anti-atherogenic profile. Small crossover study — supports plausibility of the endothelial signal rather than a hard clinical outcome.
  3. Salden BN, Troost FJ, de Groot E, Stevens YR, Garces-Rimon M, Possemiers S, et al. Randomized clinical trial on the efficacy of hesperidin 2S on validated cardiovascular biomarkers in healthy overweight individuals. The American Journal of Clinical Nutrition. 2016;104(6):1523-1533. doi: 10.3945/ajcn.116.136960.PubMedUsed to support: Backs the endothelial-function signal with honest limits: 6-week pure hesperidin-2S did NOT significantly change flow-mediated dilation — its primary endpoint — versus placebo; only a pre-specified subgroup showed benefit, and other cardiovascular biomarkers and blood pressure were largely unchanged. At best a modest, subgroup-level signal, not a demonstrated effect.
  4. Martinez-Zapata MJ, Vernooij RW, Uriona Tuma SM, Stein AT, Moreno RM, Vargas E, et al. Phlebotonics for venous insufficiency. Cochrane Database of Systematic Reviews. 2016;4(4):CD003229. doi: 10.1002/14651858.CD003229.pub3.PubMedUsed to support: Backs the chronic-venous-insufficiency use, honestly framed: this Cochrane review found phlebotonics (including diosmin+hesperidin/flavonoids) probably reduce edema and some CVI symptoms, but evidence quality is low-to-moderate and isolated-hesperidin data are limited because most trials use combination products.